Sten L. Cornelissen

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications

Divergence of DNA tumor mutations in cerebrospinal fluid in metastatic breast cancer patients with leptomeningeal metastases.

Divergence of DNA tumor mutations in cerebrospinal fluid in metastatic breast cancer patients with leptomeningeal metastases.

Journal: Breast (Edinburgh, Scotland)
Published: September 10, 2025

Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis from the phase 2 PRADO-trial.

Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis from the phase 2 PRADO-trial.

Journal: Nature medicine
Published: July 10, 2025

Neoadjuvant ipilimumab and nivolumab in resectable cutaneous squamous cell carcinoma: a randomized phase 2 trial.

Neoadjuvant ipilimumab and nivolumab in resectable cutaneous squamous cell carcinoma: a randomized phase 2 trial.

Journal: Nature medicine
Published: December 09, 2024

Combined Cabazitaxel and Carboplatin Treatment of Metastatic Castration Resistant Prostate Cancer Patients, With Innate or Acquired Resistance to Cabazitaxel Monotherapy.

Combined Cabazitaxel and Carboplatin Treatment of Metastatic Castration Resistant Prostate Cancer Patients, With Innate or Acquired Resistance to Cabazitaxel Monotherapy.

Journal: Clinical genitourinary cancer
Published: October 31, 2023

Author Correction: Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk.

Author Correction: Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk.

Journal: Nature genetics
Published: September 26, 2023

Characterization of the Tumor Microenvironment of De Novo Oligometastatic Breast Cancer in a Nationwide Cohort.

Characterization of the Tumor Microenvironment of De Novo Oligometastatic Breast Cancer in a Nationwide Cohort.

Journal: JCO precision oncology
Published: September 22, 2023

Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naïve patients with triple-negative breast cancer.

Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naïve patients with triple-negative breast cancer.

Journal: ESMO open
Published: September 13, 2023

Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patients according to BRCA1 status.

Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patients according to BRCA1 status.

Journal: BMC medicine
Published: July 21, 2023

Breast cancer genomes from CHEK2 c.1100delC mutation carriers lack somatic TP53 mutations and display a unique structural variant size distribution profile.

Breast cancer genomes from CHEK2 c.1100delC mutation carriers lack somatic TP53 mutations and display a unique structural variant size distribution profile.

Journal: Breast cancer research : BCR
Published: March 13, 2023

IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma.

IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma.

Journal: The Journal of experimental medicine
Published: November 14, 2022

A pan-cancer analysis of the microbiome in metastatic cancer.

A pan-cancer analysis of the microbiome in metastatic cancer.

Journal: Cell
Published: October 11, 2022

Immune landscape of breast tumors with low and intermediate estrogen receptor expression.

Immune landscape of breast tumors with low and intermediate estrogen receptor expression.

Journal: NPJ breast cancer
Published: June 23, 2022
Showing 1-12 of 49

Last Updated: 09/26/2026